Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-13

Clinical Trial Update: Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia [Phase 4]

View source ↗

Summary

Phase 4 trial reported on the efficacy and tolerability of nicotinamide plus cream for moderate acne vulgaris in Indonesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • nicotinamide plus cream (nicotinamide)

Snippet

Sponsor: Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED